Catherine Waldby

Stem Cells, Tissue Cultures and the Production of Biovalue

This article examines some of the social and philosophical implications of stem cell technologies. Stem cell technologies promise to transform the way that healthy tissues for transplant are sourced and circulated; from a social economy in which citizens donate whole organs to others, to one in which embryos are a major source of therapeutic tissues. This article considers the transformations in concepts of health, bodily relationships and social indebtedness that such a shift might entail. Using the concept of biovalue, this article describes the ways embryos are biologically engineered to act as tissue sources, and considers the relationship between biovalue, health and capital value. It discusses the effects stem cell technologies may have on concepts of the healthy body, particularly on the temporality of ageing, and on understandings of the human more generally.

THE BIOPOLITICS OF REPRODUCTION Post-Fordist Biotechnology and Women's Clinical Labour

cases, they are proving ineffective, as women and couples prioritise economic security and career development over the production of large families. The reasons for this shift in priorities are complex, intertwined, as Neilson notes above, with transformations in the biopolitical ordering of life. 3 These transformations could be summarised as the neoliberalisation of life, both in the sense of the everyday life of citizens, and the biological life of populations. The decline in reproduction demonstrates these two forms very succinctly. In the realm of everyday

Oocyte markets: women's reproductive work in embryonic stem cell research

Somatic cell nuclear transfer (SCNT) research, otherwise known as therapeutic cloning, requires large numbers of research oocytes, placing pressure on an already limited supply. In the UK, Canada, Australia, Singapore and most of Western Europe, oocytes are made available through modestly reimbursed donation, and, owing to the onerous nature of donation, the existing demand for reproductive oocytes far outstrips availability. SCNT research will place this system under even greater pressure. This paper investigates the growth in a global market for oocytes, where transnational IVF clinics broker sales between generally poor, female vendors and wealthy purchasers, beyond the borders of national regulation, and with little in the way of clinical or bioethical scrutiny. It considers the possible impact that SCNT research will have on this global market. It argues that oocyte vending could be understood as a kind of reproductive labor in the bioeconomy, and suggests some ways to improve the protection, security and power of vendors.

From reproductive work to regenerative labour: The female body and the stem cell industries

The identification and valorization of unacknowledged, feminized forms of economic productivity has been an important task for feminist theory. In this article, we expand and rethink existing definitions of labour, in order to recognize the essential economic role women play in the stem cell and regenerative medicine industries, new fields of biomedical research that are rapidly expanding throughout the world. Women constitute the primary tissue donors in the new stem cell industries, which require high volumes of human embryos, oöcytes, foetal tissue and umbilical cord blood. Such material is generally given for free in the advanced industrial democracies, constituted as a surplus (‘spare’ embryos) or waste (umbilical cord ‘afterbirth’, cadaveric foetuses, poor quality oöcytes) whose generative powers should not be withheld from others. At the same time, among impoverished female populations in developing nations, such biological material is now often procured through frankly transactional relations, where women undertake risky procedures for small fees. In each case, female bodily productivity is mobilized to support bioeconomic research, yet the economic value involved in these relations is largely unacknowledged. In this article, we consider both the gift economy and the transactional economy for reproductive tissues as a form of labour. In order to fully conceptualize the specificities of feminized productivity in the bioeconomy, we distinguish between earlier feminist theories of reproductive labour and the emerging practices generated by stem cell research, which we term regenerative labour. We consider how historical transformations in the regulation of feminized labour and the technical repertoires of stem cell research renegotiate the productivity limits of female reproductive biology, opening it out to novel and profitable forms of surplus value and enrolling women in complex negotiations over their role in bioeconomic activity.

National Biobanks: Clinical Labor, Risk Production, and the Creation of Biovalue

The development of genomics has dramatically expanded the scope of genetic research, and collections of genetic biosamples have proliferated in countries with active genomics research programs. In this essay, we consider a particular kind of collection, national biobanks. National biobanks are often presented by advocates as an economic ‘‘resource’’ that will be used by both basic researchers and academic biologists, as well as by pharmaceutical diagnostic and clinical genomics companies. Although national biobanks have been the subject of intense interest in recent social science literature, most prior work on this topic focuses either on bioethical issues related to biobanks, such as the question of informed consent, or on the possibilities for scientific citizenship that they make possible. We emphasize, by contrast, the economic aspect of biobanks, focusing specifically on the way in which national biobanks create biovalue. Our emphasis on the economic aspect of biobanks allows us to recognize the importance of what we call clinical labor—that is, the regularized, embodied work that members of the national population are expected to perform in their role as biobank participants—in the creation of biovalue through biobanks. Moreover, it allows us to understand how the technical way in which national biobanks link clinical labor to databases alters both medical and popular understandings of risk for common diseases and conditions.

Biomedicine, tissue transfer and intercorporeality

More and more areas of medicine involve subjects donating tissues to another — blood, organs, bone marrow, sperm, ova and embryos can all be transferred from one person to another. Within the technical frameworks of biomedicine, such fragments are generally treated as detachable things, severed from social identity once they are removed from a particular body. However an abundant anthropological and sociological literature has found that, for donors and patients, human tissues are not impersonal. They retain some of the values of personhood and identity, and their incorporation often has complex effects on embodied identity. This article draws on feminist philosophy of the body to think through the implications of some of these practices. Specifically, it draws on the idea of intercorporeality, wherein the body image is always the effect of embodied social relations. While this approach is highly productive for considering the stakes involved in tissue transfer, it is argued that the concept of body image has been too preoccupied with the register of the visual at the expense of introceptive data and health/illness events. Empirical data around organ transplant and sperm donation are used to demonstrate that the transfer of biological fragments involves a profound kind of intercorporeality, producing identifications and disidentifications between donors and recipients that play out simultaneously at the immunological, psychic and social levels.

Umbilical Cord Blood: From Social Gift to Venture Capital

Umbilical cord blood has proved an effective substitute for bone marrow in the treatment of blood disorders, and most nations in the developed world have public programmes for the harvesting and storage of cord blood for allogenic transplantation. Private cord blood banks have sprung up alongside public banks, offering parents the opportunity to bank their childs cord blood for later personal use. Private cord blood banking has been largely condemned by bioethical and medical professional bodies, on the grounds that the likelihood of any particular individual needing a cord blood transplant is very low, and that public, redistributive banking is a more efficient use of resources. This article investigates the appeal of private cord blood banking in the face of such condemnation, and the social norms implied in public and private cord blood banking. It locates cord blood banking in the field of regenerative medicine, and considers the two different models of biological regeneration implied in public, gift-based banking and private, autologous banking. In the first case, regeneration of sick bodies is an effect of social redistribution and intercorporeal generosity between citizens. In the second, regeneration is promised by the retention of cord blood as a form of personal property. The private cord blood account appeals to certain neoliberal norms of entrepreneurial embodiment, acting as a kind of asset or venture capital invested in the future of biotechnological innovation.

‘Banking time’: egg freezing and the negotiation of future fertility

This paper examines the relatively recent practice of non-medical egg freezing, in which women bank their eggs for later use in conceiving a child. Non-medical egg freezing has only been available for about the last five years, as new vitrification techniques have made the success rates for actual conception more reliable than the earlier method of slow freezing. I draw on interviews with both clinicians and women who have banked their eggs to consider how this novel practice articulates with broader issues about the relationship between sexuality, reproduction and the political economy of household formation. Non-medical egg-freezing provides a technical solution to a number of different problems women face with regard to the elongation of the life course, the extension of education, the cost of household establishment and the iterative nature of relationship formation, thematised by the ubiquity of internet dating among the interviewees. I focus on the ways women used egg freezing to manage and reconcile different forms of time.

Biobanking in Singapore: post-developmental state, experimental population

Like other wealthy states in East Asia, Singapore is busy building a bioeconomy. The government has allocated billions of dollars to life sciences research, under the aegis of the Biomedical Sciences Initiative (BMSI). This paper focuses on one important life sciences research project to consider some of the biopolitical implications of bioeconomic development, in Singapore, but also more generally. This project is the Singapore Consortium for Cohort Studies (SCCS), a large prospective population cohort, designed to track gene environment interactions in metabolic disease, specifically type 2 diabetes and ischemic heart disease. I use the Singapore Consortium for Cohort Studies as a site to examine the question: how are populations figured in bioeconomic development? To put it another way, what are the biopolitics of the bioeconomy? The Singapore example is telling, both because the rate of bioeconomic development is so startling and because it forms an explicit element in the states attempt to reposition the national population in the global economy.

Revenants: The Visible Human Project and the Digital Uncanny

No domain of experience, no matter how personal or particular, seems immune to translation into data...